Client of Farmavita.Net is looking for EU CTD Dossier with bulk supply of Famotidine.
License territory would be Poland. Licensee is established company with well developed sales and distribution capability.
Please, contact us for more details.
Famotidine (INN) (pronounced /fəˈmɒtɪdiːn/) is a histamine H2-receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD). It is commonly marketed by J&J/Merck under the trade names Pepcidine and Pepcid. Unlike cimetidine, the first H2 antagonist, famotidine has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other drugs.
|Pharma licensing||In-licensing (demand)|